Weekly Paclitaxel in the Treatment of Advanced or Metastatic Breast Cancer Previously Treated or Not Treated with Docetaxel: A Phase II StudyReiki Nishimura, Kazuo Tamura, Takao Shibata et al.|Chemotherapy|2005Cited by 13
Dose Escalation Study of Epirubicin and Docetaxel in Patients with Advanced or Recurrent Breast CancerIchiro Ichinose, Kazuo Tamura, Shoshu Mitsuyama et al.|Chemotherapy|2008Cited by 6
Neoadjuvant epirubicin/docetaxel (ET) concomitant chemotherapy for primary breast cancer with tumor diameter >=3.1 cm: results of the Kyushu ET therapy phase II trial.Reiki Nishimura, Kazuo Tamura, Yoshiaki Rai et al.|PubMed|2012Cited by 3
A randomized controlled study comparing CMF plus TAM with UFT plus TAM as postoperative adjuvant therapy in women with node-positive breast cancerHideo Inaji, Tomoyuki Suzuki, Y. Park et al.|Journal of Clinical Oncology|2004Cited by 2
[Docetaxel in combination with epirubicin as the first-line chemotherapy for advanced and recurrent breast cancer: a multicenter phase II study].Keisei Anan, Kazuo Tamura, Maki Tanaka et al.|PubMed|2012Cited by 0